GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Aidea Pharmaceutical Co Ltd (SHSE:688488) » Definitions » Issuance of Debt

Jiangsu Aidea Pharmaceutical Co (SHSE:688488) Issuance of Debt : ¥444.9 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Jiangsu Aidea Pharmaceutical Co Issuance of Debt?

Jiangsu Aidea Pharmaceutical Co's Issuance of Debt for the three months ended in Sep. 2024 was ¥148.7 Mil.

Jiangsu Aidea Pharmaceutical Co's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was ¥444.9 Mil.


Jiangsu Aidea Pharmaceutical Co Issuance of Debt Historical Data

The historical data trend for Jiangsu Aidea Pharmaceutical Co's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Aidea Pharmaceutical Co Issuance of Debt Chart

Jiangsu Aidea Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial 132.00 60.00 - 205.00 395.29

Jiangsu Aidea Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.99 95.90 140.30 60.00 148.67

Jiangsu Aidea Pharmaceutical Co Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥444.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiangsu Aidea Pharmaceutical Co Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Jiangsu Aidea Pharmaceutical Co's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Aidea Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2 Liuzhuang Road, Hanjiang District, Jiangsu Province, Yangzhou, CHN, 225008
Jiangsu Aidea Pharmaceutical Co Ltd produces and sells human-derived protein products, and also develops some generic drug businesses and distributes Abbott's HIV diagnostic equipment and reagents. The company focuses on development of new chemical entities of anti-tumor, anti-virus and cardiovascular areas, among which two NCE drugs for the treatment of Cancer and AIDS have been approved.
Executives
Wang Jun Directors, senior managers
Fu He Liang Director, core technical staff
Zhang Jie Directors, senior managers
Yuan Yu Core technical personnel
Su Gu Fang Core technical personnel
Zhang Ji Bing Core technical personnel
Wang Guang Rong Directors, senior managers
Yu Ke Directors, senior managers

Jiangsu Aidea Pharmaceutical Co Headlines

No Headlines